HCA Healthcare Names Dr. Michael Cuffe Executive Vice President, Chief Clinical Officer
October 25 2021 - 4:30PM
Business Wire
HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading
healthcare providers, today announced Michael Cuffe, MD, MBA, will
become executive vice president and chief clinical officer of HCA
Healthcare, effective January 1, 2022.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20211025005784/en/
HCA Healthcare Names Dr. Michael Cuffe
Executive Vice President, Chief Clinical Officer (Photo: Business
Wire)
In his new role, Dr. Cuffe will be responsible for the company’s
clinical agenda. He will lead multiple areas including clinical
quality, nursing, care transformation, and clinical informatics. He
will also continue his existing responsibilities of leading
physician services, which includes urgent care operations, graduate
medical education (GME), laboratory services and more than 13,000
employed and managed physicians.
“Dr. Cuffe is a respected clinical and operational leader with a
deep understanding of HCA Healthcare’s culture and operations,”
said Sam Hazen, chief executive officer of HCA Healthcare. “His
clinical background, passion for clinical excellence, and proven
leadership at HCA Healthcare make him the right person to support
our caregivers, integrate services across the organization, and
advance our clinical quality agenda.”
Dr. Cuffe joined HCA Healthcare in 2011 as president and CEO of
physician services. Under Dr. Cuffe’s leadership, HCA Healthcare
has become the largest sponsor of GME programs in the United
States, training more than 5,000 residents and fellows across 61
teaching hospitals. In addition, during his ten years with HCA
Healthcare, Dr. Cuffe’s teams have expanded the scope of support
they provide to the organization’s physician partners and residents
while also broadening the network of care offered to patients
through the growth of the company’s urgent care operations.
Prior to HCA Healthcare, Dr. Cuffe served as vice president for
Ambulatory Services and chief medical officer for Duke University
Health System. He previously served as vice president medical
affairs of Duke University Health System and vice dean for the Duke
University School of Medicine. Dr. Cuffe is a graduate of MIT, and
received his MD and MBA degree from Duke University. He completed
his residency in internal medicine and fellowship in cardiology at
Duke University.
Previously, the clinical agenda for the organization was led by
Jonathan Perlin, MD, Ph.D., who is leaving to become the president
of The Joint Commission. Dr. Perlin joined HCA Healthcare in 2006
and established a clinical services organization that uses health
information technology and data science to seek to continually
improve care and create new clinical protocols. Under Dr. Perlin’s
leadership, HCA Healthcare produced the landmark REDUCE MRSA study
that demonstrated significant improvements for reducing bloodstream
infections, creating a new standard of care.
“I am grateful for Jon’s dedicated service to HCA Healthcare and
his continued focus on clinical quality,” said Hazen. “As a leader
of our organization for many years, the research and work of his
teams have significantly improved care for our patients. We wish
him well as he continues to make an impact in healthcare and in the
lives of patients.”
About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation’s leading
providers of healthcare services comprising 183 hospitals and
approximately 2,000 ambulatory sites of care, including surgery
centers, freestanding ERs, urgent care centers, and physician
clinics, in 20 states and the United Kingdom. With its founding in
1968, HCA Healthcare created a new model for hospital care in the
United States, using combined resources to strengthen hospitals,
deliver patient-focused care and improve the practice of medicine.
HCA Healthcare has conducted a number of clinical studies,
including one that demonstrated that full-term delivery is
healthier than early elective delivery of babies and another that
identified a clinical protocol that can reduce bloodstream
infections in ICU patients by 44 percent. HCA Healthcare is a
learning health system that uses its more than 32 million annual
patient encounters to advance science, improve patient care and
save lives. Please click here to connect with HCA Healthcare on
social media.
All references to “Company,” “HCA” and “HCA
Healthcare” as used throughout this document refer to HCA
Healthcare, Inc. and its affiliates
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211025005784/en/
INVESTOR CONTACT: Mark Kimbrough 615-344-2688
MEDIA CONTACT: Harlow Sumerford 615-344-1851
HCA Healthcare (NYSE:HCA)
Historical Stock Chart
From Mar 2024 to Apr 2024
HCA Healthcare (NYSE:HCA)
Historical Stock Chart
From Apr 2023 to Apr 2024